Closed transaction

Sale of Larodan, a Swedish life science company in the research lipids space

Advised by
Client
Counterparty
Deal stage
Closed transaction
Service
Sell
Sector
Healthcare
Sub-sector
Biotech/Pharma Services
Market
EMEA
Contact
hew@evli.com

Deal details

We are selling a small Swedish life science company in the reearch lipids space. The company is Larodan (https://www.larodan.com/), which is mainly a provider of lipids used for analysis and research within pharma, food / agro and academia. The main use is as reference standards in analysis and the second largest segment is reagents in research / product development. The company is based in Stockholm, and is today owned by two individuals. During 2019 the company had sales of ca. USD 2.5m with 25% EBITDA margin. Ca. 70% of sales represent the company’s own lipids where the gross margin is around +80%. The remainder of sales come from distribution of research chemicals and lipids in the Nordics. Of the sales of own lipids ca. 90% is exported outside the Nordics.

If you have any ideas of potential buyers you would like to introduce this to, ideas are very welcome. Likely deal value is somewhere around USD 4-6m.

Henrik Westling Evli Corporate Finance AB Henrik joined Evli in May 2002 following Evli’s acquisition of Arthur Andersen’s Nordic Corporate Finance operations. View profile

More by Evli Corporate Finance AB

More deals in Healthcare

Sell-side advisory

Allied Group has acquired majority stake in Tzamal Medical.

Where
Israel
Year
2026
Sell-side advisory

PharmaX Solutions was sold to BioPhorum.

Where
Germany
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Germany
Year
2025

More Healthcare

More deals in Europe

Sell-side advisory

Ocean Property Services Group sold to Lomond.

Where
United Kingdom
Year
2026
Advisory

John Henry Group.

Where
United Kingdom
Year
2026
Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

Fibreactive sold to discoverIE Group plc.

Where
United Kingdom
Year
2026

More Europe

Membership

Gain worldwide reach with CapFive M&A professionals

The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.

Become a member

Get in touch

Find an adviser.

From a first valuation to signed completion, CapFive member firms advise on sell-side, buy-side, corporate finance and debt.

Share what you are planning and we will connect you with an adviser who has done it before, and who can bring in colleagues across borders when the deal needs them.

Contact us